Financhill
Back

Bio-Rad Laboratories Quote, Financials, Valuation and Earnings

Bio-Rad Laboratories Price Quote

$340.66
+7.00 (+2.1%)
(Updated: September 18, 2024 at 6:55 PM ET)

Bio-Rad Laboratories Key Stats

Sell
50
Bio-Rad Laboratories (BIO) is a Sell

Day range:
$330.16 - $340.57
52-week range:
$261.59 - $370.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.74
P/B ratio:
1.37%

Volume:
244.1K
Avg. volume:
212.7K
1-year change:
-11.31%
Market cap:
$9.3B
Revenue:
$2.7B
EPS:
$-47.03

How Much Does Bio-Rad Laboratories Make?

Is Bio-Rad Laboratories Growing As A Company?

  • What Is Bio-Rad Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.06%
  • What Is Bio-Rad Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Bio-Rad Laboratories Stock Price Performance

What Is Bio-Rad Laboratories 52-Week High & Low?

Bio-Rad Laboratories Price To Free Cash Flow

Is It Risky To Buy Bio-Rad Laboratories?

Is Bio-Rad Laboratories Cash Flow Positive?

  • What Is BIO Cash Flow From Operations?
    Cash flow from operations (TTM) is $346.2M
  • What Is Bio-Rad Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$323.8M
  • What Is Bio-Rad Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$11.3M

Bio-Rad Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    BIO return on invested capital is -13.98%
  • What Is Bio-Rad Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is -11.34%
  • What Is BIO Return On Equity?
    ROE is a measure of profitability and is -16%

Bio-Rad Laboratories Earnings Date & Stock Price

Bio-Rad Laboratories Competitors

Bio-Rad Laboratories Dividend Yield

Bio-Rad Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.29%
Revenue: -6.26% -1.23%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 380.17
Upside from Last Price: 13.94%

Major Shareholders

  • How many BIO shares are owned by institutional investors?
    27.9M BIO shares are owned by institutional investors
  • How many BIO shares are owned by insiders?
    5.4M BIO shares are owned by insiders